Amphotericin B in the treatment of Candida cholecystitis

P. C. Adamson, M. G. Rinaldi, P. A. Pizzo, T. J. Walsh

Research output: Contribution to journalArticlepeer-review

Abstract

Invasive candidiasis is a significant problem in immunocompromised patients. Candida cholecystitis, an uncommon complication of immunosupression, has been increasingly reported. Little is known, however, about the management of Candida cholecystitis or the pharmacokinetics of antifungal agents in the biliary tract. We therefore report the biliary pharmacokinetics of amphotericin B and the management of a child with cholecystitis caused Candida albicans.

Original languageEnglish (US)
Pages (from-to)408-411
Number of pages4
JournalPediatric Infectious Disease Journal
Volume8
Issue number6
StatePublished - Jan 1 1989

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Amphotericin B in the treatment of Candida cholecystitis'. Together they form a unique fingerprint.

Cite this